Tarsus Pharmaceuticals Inc

NASDAQ:TARS   3:59:16 PM EDT
24.94
-1.06 (-4.08%)
Earnings Announcements

Tarsus Pharmaceuticals Reports Qtrly Loss Per Share $0.76

Published: 11/09/2021 22:48 GMT
Tarsus Pharmaceuticals Inc (TARS) - Tarsus Pharmaceuticals, Inc. Reports Third Quarter 2021 Financial Results and Recent Business Achievements.
Tarsus Pharmaceuticals Inc- Qtrly Loss per Share $0.76.
Revenue is expected to be $6.69 Million
Adjusted EPS is expected to be -$0.70

Next Quarter Revenue Guidance is expected to be $6.69 Million
Next Quarter EPS Guidance is expected to be -$0.71

More details on our Analysts Page.